Answers are grounded in this paper and cite their sources.
The increasing prevalence of antimicrobial resistance has intensified the search for stable bio-based antimicrobial agents for food and therapeutic applications. In this study, a novel proteinaceous postbiotic peptide, designated Postbiotin-E8, was isolated from an environmental Lacticaseibacillus sp. E8 strain. Sequential purification using ethanol precipitation, cation-exchange chromatography and RP-HPLC resulted in a 4.15-fold increase in specific activity with 29% recovery. Tricine-SDS-PAGE, MALDI-TOF, and LC-MS analyses confirmed a homogeneous peptide with a molecular mass of approximately 3.75 kDa. N-terminal sequencing identified a unique 33-amino-acid sequence enriched in hydrophobic and cationic residues, consistent with an amphipathic antimicrobial peptide. Postbiotin-E8 exhibited substantial physicochemical stability, retaining antimicrobial activity across a broad pH range (4–8), moderate thermal conditions (up to 50°C), and in the presence of selected detergents and organic solvents. The peptide demonstrated broad-spectrum antibacterial activity against Escherichia coli, Bacillus cereus, Staphylococcus aureus, and Salmonella Typhi. Growth inhibition, bactericidal activity after 24 h exposure, and antibiofilm assays demonstrated concentration-dependent antibacterial activity and effective inhibition of biofilm formation against S. aureus and S. Typhi . Furthermore, Postbiotin-E8 improved the microbiological, physicochemical, visual and sensory stability of refrigerated milk, indicating its potential as a natural bio-preservative. These findings identify Postbiotin-E8 as a structurally distinct antimicrobial peptide with potential applications in food biopreservation, surface decontamination and future therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Totala et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: